ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.93 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,001 | -22.0% | 2,149 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $16,676 | -87.0% | 2,149 | -75.3% | 0.00% | -50.0% |
| Q4 2021 | $127,993 | -28.4% | 8,707 | +1.9% | 0.00% | -33.3% |
| Q3 2021 | $178,697 | +38.5% | 8,546 | +17.2% | 0.00% | +50.0% |
| Q2 2021 | $128,995 | -20.3% | 7,292 | +10.4% | 0.00% | 0.0% |
| Q1 2021 | $161,798 | -27.6% | 6,604 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $223,545 | +108.0% | 6,604 | +107.2% | 0.00% | +50.0% |
| Q2 2020 | $107,498 | – | 3,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,007,576 | $25,199,000 | 12.12% |
| Svennilson Peter | 4,768,181 | $119,252,000 | 9.73% |
| EcoR1 Capital, LLC | 2,642,218 | $66,082,000 | 4.71% |
| Orbimed Advisors | 2,921,967 | $73,078,000 | 0.92% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 312,483 | $7,815,000 | 0.35% |
| EMERALD ADVISERS, LLC | 324,582 | $8,118,000 | 0.33% |
| Casdin Capital, LLC | 251,515 | $6,290,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 995,382 | $24,895,000 | 0.24% |
| Artal Group S.A. | 142,500 | $3,564,000 | 0.09% |
| Alyeska Investment Group, L.P. | 161,585 | $4,041,000 | 0.06% |